Consent Tracking for Clinical Samples

Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use. 

 

In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem. 

 

She describes:

• How consent is or has been documented
• The benefits of electronic consent documentation
• Specific consent attributes, e.g. genetic testing
• Handling consent requirements from different countries or institutions
• Understanding consent for future use, including limitations and expirations

Learn more at https://www.q2labsolutions.com/labmatrix